(Q42540926)

2 November 2017

title

Synthesis and antiviral evaluation of analogs of adenosine-N1-oxide and 1-(Benzyloxy)adenosine (English)

1 reference

2 November 2017

Kwong CD

1

1 reference

2 November 2017

Krauth CA

2

1 reference

2 November 2017

Shortnacy-Fowler AT

3

1 reference

2 November 2017

Arnett G

4

1 reference

2 November 2017

Hollingshead MG

5

1 reference

2 November 2017

Shannon WM

6

1 reference

2 November 2017

Montgomery JA

7

1 reference

2 November 2017

Secrist JA 3rd

8

1 reference

2 November 2017

publication date

1 August 1998

1 reference

Nucleosides & nucleotides

2 November 2017

published in

1 reference

2 November 2017

volume

17

1 reference

2 November 2017

issue

8

1 reference

2 November 2017

page(s)

1409-1443

1 reference

Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Novel viral vaccines for livestock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Recombinant viral vector vaccines for the veterinary use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Applications of pox virus vectors to vaccination: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Antiviral agents. 1-Aralkyloxyadenosines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07328319808003478

10.1080/07328319808003478

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference